Why I Give: Neal Roberts and Hal Nathan on making a global impact
“Over the years, we’ve figured out various ways to do good in the world.”
Why I Give: David Anderson on supporting accessible science
David Anderson was looking for ways to support research at La Jolla Institute for Immunology (LJI) long before the COVID-19
Why I Give: Barbara Donnell on the importance of endurance—and hope
For Barbara Donnell, La Jolla Institute for Immunology (LJI) has always been a place for inspiration and collaboration. The San
Up and Coming: Haoyang Li, Ph.D. – An Inspired Vaccine
Haoyang Li, Ph.D., is no stranger to quarantine. He was in high school in China when SARS came knocking. “My
The world goes crazy around you
The pace of research for La Jolla Institute for Immunology’s Coronavirus Task Force is intense. Samples come in, data come out. Some labs are running 24-7. LJI scientists have brought us closer to ending the pandemic. They’ve also missed months of family dinners and bedtime stories. Missed sleep. Missed the before days. This is the story—in the researchers’ own words—of how LJI’s dedicated scientists took on COVID-19.
Daniela Weiskopf Awarded $1.4 million to Study COVID-19 in Latino Americans
LA JOLLA, CA—Latino Americans have been hit very hard by the COVID-19 pandemic. In fact, the U.S. Centers for Disease
How Pandemics End
Nearly every pandemic has had an arc. A disease spreads, it kills, it stops. We don’t yet know how the
Every COVID-19 case seems different. These scientists want to know why.
LA JOLLA—As scientists around the world develop life-saving COVID-19 vaccines and therapies, many are still wondering exactly why the disease
New look at COVID-19 cases does not support link between BCG vaccination and lower mortality
Researchers tracking COVID-19 mortality early in the pandemic noticed that some countries had a significantly lower mortality rate than others.
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
LA JOLLA, CA—Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more
Beating HIV and COVID-19 may depend on tweaking vaccine molecules
LA JOLLA—Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune
LJI Professor Erica Ollmann Saphire awarded $6.4 million for international efforts to beat COVID-19
LA JOLLA—The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has awarded more